Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation

Adaptive Health

Status: Terminated

Conditions: Depression

Treatments: Device: IntelliCare; Behavioral: Treatment as Usual (TAU)

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04499729

R44MH114725

Details and patient eligibility

About

The overarching aim of the proposed project is to conduct a pragmatic, quality improvement evaluation of the IntelliCare Platform for improving processes of care in the Rush Collaborative Care program, and improving patient population depression outcomes, to determine the long-term utility of IntelliCare for Rush.

Full description

This study is a pragmatic, system-wide rollout quality improvement evaluation design displayed in Figure 1. The Rush IRB has waived consent for this quality improvement trial. Data from the EHR will be used beginning December 1, 2019. The first care manager (CM) will begin enrolling patients into IntelliCare in September, 2020. Additional CMs will begin using IntelliCare at approximately 3 month intervals. In September 2021, support for IntelliCare from the evaluation team will be withdrawn, to examine the sustainability of the IntelliCare Platform.

Patients Data from all patients, aged 18 or older, enrolled collaborative care from December 1, 2019 through August 31, 2022 will be used to evaluate the IntelliCare service. All CCT patients who are 18 or older, and have a smartphone will be offered enrollment.

Enrollment: 318 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Enrolled in Rush Collaborative Care service
• Owns a personal smartphone

Exclusion criteria

• None

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

318 participants in 2 patient groups

Treatment as Usual (TAU)

Active Comparator group

Description:

TAU will be the treatment that is provided through the Rush Collaborative Care program as part of their service

Treatment:

Behavioral: Treatment as Usual (TAU)

IntelliCare

Experimental group

Description:

Patients will be offered IntelliCare as part of their care in the Rush Collaborative Care service. Patients who agree will download the IntelliCare app, which provides self management and collects symptom self-report data. Symptom severity scores are displayed to the care manager, allowing them to manage the patient's care. The app also provides a secure messaging service for communication between the care manager and the patient.

Treatment:

Device: IntelliCare